AR

Active Director Director DIN 03428092
DIN 03428092 First appointment Feb 2011 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2011
Shareholding value •••• Premium profile

About Asha Rani

Data last updated:

Asha Rani is a Director at Sri Jagan Medicals Private Limited (since 2011). The company operates in Healthcare. Sri Jagan Medicals Private Limited reported revenue of ₹2.88 Cr (FY 2025).

DIN 03428092
Primary Designation Director
Industry Healthcare
First Appointment 17 Feb 2011
Oldest Company Age 17 yrs
Largest company Sri Jagan Medicals Private Limited · ₹2.88 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sri Jagan Medicals Private Limited U24232DL2009PTC188751
Director17 Feb 20112009₹2.88 Cr (FY 2025)Active

Board colleagues of Asha Rani

NameDINCompanyDesignation
Sunil Pawar02462558Sri Jagan Medicals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sri Jagan Medicals Private Limited
Premium access

Shareholding and investment profile for Asha Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asha Rani

Asha Rani currently holds 1 directorship: Sri Jagan Medicals Private Limited (Director, since 17 Feb 2011, revenue ₹2.88 Cr (FY 2025)).

Asha Rani was first appointed on 17 Feb 2011 as Director at Sri Jagan Medicals Private Limited.

The current boards of Asha Rani's companies include Sunil Pawar (Sri Jagan Medicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available